Background and Purpose-In the United States, black Americans exhibit a greater risk of stroke and burden of stroke risk factors than whites; however, it is unclear whether these stroke risk factors influence stroke risk differently across racial groups. Methods-In total, 126 018 participants of the Women's Health Initiative (11 389 black and 114 629 white women), free of stroke and coronary heart disease at baseline (1994-1998), were followed through 2010. Participants completed baseline clinical exams with standardized measurements of blood pressure and anthropometrics, medication inventory and selfreported questionnaires on sociodemographics, behaviors/lifestyle, and medical history. Incident total, ischemic and hemorrhagic strokes were updated annually through questionnaires with medical record confirmation. Rate differences (per 100 000 person-years) and hazard ratios (HR) based on multivariable Cox models and were estimated. Results-Over a median of 13 years, 4344 stroke events were observed. Absolute incidence rates were higher in black than white women in each age group. In age-adjusted analyses, the risk of stroke was significantly higher among black compared with white women (HR=1.47, 95% CI, 1.33-1.63); adjustment for stroke risk factors, which may be on the causal pathway, attenuated the estimate. Racial disparities were greatest among women 50 to <60 years (HR=3.48; 95% CI, 2.31-5.26; rate difference =99) and diminished with increasing age (60 to <70 HR=1.80; 95% CI, 1.50-2.16; rate difference =107; ≥70 years: HR=1.26; 95% CI, 1.10-1.43; rate difference =87; P interaction <0.001). Black women 50 to <60 years remained at significantly higher risk than white women after adjustment for stroke risk factors (HR=1.76; 95% CI, 1.09-2.83). Conclusions-There was a moderately greater risk of total stroke among black compared with white women; however, racial disparities were greatest among women aged 50 to <60 years. Interventions targeted at younger black women may provide the greatest benefit in reducing disparities. (Stroke. 2019;50:797-804.
T he US Health and Human Services Healthy People 2020 goals aim to attain health equity for all by eliminating disparities. 1 However in 2014, stroke was the fifth leading cause of death across all Americans, but the third leading cause among black. 2 Data from the REGARDS study (Reasons for Geographic and Racial Differences in Stroke) demonstrated that racial disparities in stroke mortality persist despite a marginal absolute decrease of 12% over the past 30 years . 3 The root causes of these disparities are not fully understood. Evidence suggests a younger age of stroke onset among blacks, [4] [5] [6] potentially because of a heavier burden of stroke risk factors among blacks at younger ages, as early as adolescence. 7 For example, elevated systolic blood pressure (SBP) may confer a greater risk of stroke among black adults compared with whites. 8 Importantly, socioeconomic factors have demonstrated only a minimal role in explaining racial disparities in stroke compared with the contribution of traditional stroke risk factors. 3, 6 However, few studies have examined the intersection of race and sex when examining disparities in stroke, nor has the role of potential confounders been examined specifically by race and sex, potentially minimizing residual confounding. To address these limitations, we examined racial disparities in stroke risk as well as interactions
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between race, stroke risk factors, and total stroke specifically among women.
Methods

Women's Health Initiative
The Women's Health Initiative (WHI) is an ongoing prospective study of 161 808 multiethnic postmenopausal women aged 50 to 79 years recruited at 40 clinical centers in the United States, consisting of clinical trials and an observational study, as previously described. 9 Of the 68 132 women free of cardiovascular disease at baseline (1994) (1995) (1996) (1997) (1998) in the WHI-clinical trial, 10% were black, and 81.4% were white. Analyses among women enrolled in the WHI-clinical trial were restricted to the dietary modification trial and the placebo arms of the hormone trials, including women who provided follow-up through 2005 as part of the main trial and those who participated in the extension study and provided follow-up through 2010 (online-only Data Supplement). A final sample of 126 018 women was available for analyses ( Figure 1 ). Deidentified data and materials have been made publicly available at the NHLBI BioLINCC and can be accessed at (https://biolincc.nhlbi.nih.gov/search/).
Covariate Ascertainment
All participants completed baseline clinical exams with questionnaires on sociodemographic, lifestyle/behaviors, diet, medical history, and medication inventory as previously described (online-only Data Supplement). 10 In this study, women who self-reported black are referred to as black and white (not of Hispanic origin) women as white. Region of residence was assigned based on participant address at the baseline visit. Diet was categorized according to the Healthy Eating Index-2005 9,10 based on the baseline food frequency questionnaire history of diabetes mellitus, atrial fibrillation, and cancer was assessed by self-reported physician diagnosis, and hypertension status was defined by self-reported physician diagnosis and treatment with antihypertensive medication. Use of antihypertensive medication was restricted to those with a history of hypertension; however, 1.2% reported conflicting responses to antihypertensive medication use (0.6% of stroke cases). All participants who reported current use were included in analyses for current use of antihypertensive medication. Updated values of SBP and diastolic BP, body mass index (BMI), and hypertensive medication were available across all arms in the third year of follow-up.
Stroke Ascertainment
The primary end point for these analyses was total stroke (ischemic, hemorrhagic, and unknown type) with ischemic and hemorrhagic strokes examined as secondary end points. Analyses include all incident nonfatal and fatal strokes diagnosed through 2010. WHIclinical trial participants attended mandatory clinic visits through the trial, and as of 2005 completed annual mailed questionnaires ascertaining data on medical outcomes including stroke. Women in the WHI-observational study reported stroke events by annual selfreported questionnaires, direct reports or by the third party in between questionnaire cycles. 9 Fatal events were ascertained by proxy or the National Death Index. For all self-reported strokes, medical records, and death certificates were requested. Stroke diagnosis requiring hospitalization or occurring during hospitalization was defined as a rapid onset of a persistent neurological deficit, not known to be secondary to brain trauma, tumor, infection or other cause and attributed to an obstruction or rupture of the brain arterial system, lasting >24 hours without evidence for other cause, unless superseded by death or evidence of an acute stroke was available on computed tomography or magnetic resonance imaging scan. 11 Strokes were classified as ischemic stroke (thrombotic or embolic occlusion of a cerebral artery or lacunar infarction not procedure related), hemorrhagic stroke (subarachnoid, intracerebral, or other unspecified intracranial hemorrhage not procedure related), or stroke of unknown type when a stroke was documented but the type could not be ascertained. Events were locally adjudicated with central adjudication by one of 3 neurologists available for uncertain events (95% confirmation).
11
Statistical Analyses
Distributions of baseline characteristics were compared across race using χ 2 tests for categorical variables and Student t test or Wilcoxon rank-sum tests, for continuous variables, as appropriate depending on the underlying distribution. The distributions of baseline characteristics were calculated across enrollment in extended follow-up and treatment arms (online-only Data Supplement). Additionally, racespecific incidence rates (IRs) of stroke were calculated. Multivariable Cox models stratified by treatment arm and adjusted for time-varying enrollment in extended follow-up (to meet assumptions of proportional hazards) were used to estimate hazard ratios (HR) and 95% CI. Potential confounders and stroke risk factors were identified by subject matter knowledge, and white women were used as the reference to maintain comparability with previous literature.
Three nested multivariable models were used to examine the association between race and stroke. Model 1 adjusted for age at baseline, model 2 additionally adjusted for baseline values of socioeconomic-related variables, and model 3 additionally adjusted for baseline stroke risk factors (online-only Data Supplement). Effect modification of the association between race and stroke by stroke risk factors was examined in 2 ways. First, race-specific relationships between stroke risk factors and total stroke were adjusted for covariates in model 3 to address race-specific confounding. This approach highlights how confounding may influence the association between stroke risk factors and total stroke differently among black and white women, while minimizing residual confounding and allowing for race-specific comparisons. Second, the association between race and total stroke was stratified by stroke risk factors and minimally adjusted for covariates in model 1 because all other covariates may be intermediates on the causal pathway. This approach allows for the ascertainment of how racial disparities may differ across stroke risk factors. The associations between age and stroke, and race and stroke stratified by age were modeled with time-varying age to assess the role of age-at-event, with updated values of SBP, diastolic BP, BMI, and use of hypertensive medications in model 3. Statistical significance of interactions for time-varying age was assessed by a Wald test, whereas all other interactions were assessed using a likelihood ratio test (model with the main effects of race and the stroke risk Values are relative frequencies and sample, mean±STD, median (25th-75th percentiles). Student t test, Wilcoxon rank-sum test, or χ 2 test used as appropriate on nonmissing values. BMI indicates body mass index; HEI, Healthy Eating Index; and HS, high school education.
*Frequency of stroke type by race provided in Table 2 . †HEI-2005. ‡Among those with self-reported hypertension. §E-alone: controls from the estrogen alone arm; E+P controls: controls from the estrogen and progestin arm. factor of interest compared with a model including an interaction term for the main effects). P values from either method are referred to as P interaction .
Statement of Ethics
This study was approved by the institutional review board of Brigham and Women's Hospital, and all procedures were in accordance with institutional guidelines. Participants provided informed consent to participate.
Results
Overall, women in these analyses were generally healthy, demonstrated by a low prevalence of current smoking and hypertension, in addition to a high proportion of college or postgraduate education compared with women in the general US population. 12 However, mean SBP and BMI values were above the optimal range. Although black women were younger than white women, they exhibited a higher BMI and mean SBP, had a lower dietary score and were more likely to report a history of cardiovascular risk factors (P<0.01; Table 1 ).
Association Between Race and Stroke
Over 17 years of follow-up (1 496 314 person-years), we observed 4344 stroke events of which 3136 were ischemic, 708 hemorrhagic, and 500 of unknown origin. There were 410 stroke events among black women and 3934 among white women. The age-adjusted IR of stroke was higher among black women compared with whites across total and ischemic stroke (Figure 2A) . In multivariable analyses, adjusted for age, black women exhibited a 47% greater risk of total stroke compared with white women (95% CI, 1.33-1.63; Table 2 ). The association was modestly attenuated but remained statistically significant after adjusting for socioeconomic variables (model 2) and was attenuated towards the null and no longer statistically significant after adjustment for stroke risk factors (model 3). Estimates for ischemic and hemorrhagic stroke were similar to those for total stroke.
Race-Specific Associations Between Stroke Risk Factors and Total Stroke
In a fully adjusted analysis stratified by race, significant associations were observed between current smoking, diabetes mellitus, atrial fibrillation, time-varying age, and total stroke (Table 3) . Moreover, significant effect modification of the association between stroke risk factors and total stroke by race was observed for family history of stroke (Table 3) and time-varying age. In fully adjusted models, family history of stroke was associated with a modest increase in stroke among white (HR=1.16; 95% CI, 1.09-1.24) but not black women (HR=0.90; 95% CI, 0.74-1.11; P interaction =0.01). Additionally, the association between time-varying age and stroke was stronger among white women than among black women after adjustment for socioeconomic variables and stroke risk factors (P interaction <0.0001). White women aged 60 to <70 years and ≥70 years exhibited a 2.56 (95% CI, 2.01-3.26) and 7.07 (95% CI, 5.56-8.99) times greater risk of stroke compared with those 50 to <60 years; whereas, among black women, the risk was 1.38 (95% CI, 0.94-2.04) and 2.74 (95% CI, 2.26-4.12), respectively. Although the relative associations between age and stroke were higher in white women, the age-specific IR remained higher for black women in each age group ( Figure 2B ).
Association Between Race and Stroke Stratified by Stroke Risk Factors
Racial disparities in total stroke were greatest among those aged 50 to <60 years compared with older women after adjustment for covariates in model 1 Incidence rates and rate difference (RD) per 100 000 person-years (py) for racial disparities among women of the Women's Health Initiative (WHI). A, Age standardized incidence rate of stroke (total, ischemic, and hemorrhagic) by race and (B) incidence rates and RD for total stroke between black and white women by age. A, P values for differences between black and white women by stroke type (total stroke: P<0.001; ischemic stroke: P=0.03; and hemorrhagic stroke: P=0.38) and (B), incidence rates for black women (dotted line) and white women (solid line). RD and P values between black and white women by age (50-60 y: RD=99/100 000 py, P<0.0001; 60 to <70 y: RD=107/100 000 py, P<0.0001; and ≥70 y: RD=87/100 000 py, P=0.004).
covariates in model 3, including time-varying SBP, diastolic BP, BMI, and hypertension medication use, resulted in attenuation towards the null, primarily because of hypertension status, but remained statistically significant among younger women (<60: HR=1.76, 95% CI, 1.09-2.83; 60 to <70: HR=1.09, 95% CI, 0.89-1.33; and ≥70: HR=0.98, 95% CI, 0.85-1.12). Additionally, there was a greater racial disparity in stroke among women without a family history of stroke (HR=1.69; 95% CI, 1.47-1.94; P interaction =0.02), which remained statistically significant in fully adjusted models (HR=1.21; 95% CI, 1.04-1.40; P interaction =0.01; Table 4 ). Among women with hypertension, there was a suggestion that racial differences in the incidence of total stroke were only observed among those not taking antihypertensive medication; however, the interaction was not statistically significant (HR=1.42; 95% CI, 1.00-2.02; P interaction =0.08; Table 4 ).
Discussion
Among >100 000 women free of cardiovascular disease at baseline with up to 17 years of follow-up, we observed a moderate, significantly increased risk of stroke among black compared with white women. However, this association was no longer statistically significant after adjustment for traditional stroke risk factors. We observed significant variation by race of the association between time-varying age and total stroke, such that the age-related risk of stroke among older white women was higher than that observed among black women because of the higher baseline risk of stroke among younger black women; however, in all age groups black women had a higher IR of stroke than white women. Additionally, racial disparities were greater among women without a family history of stroke.
In the United States, black adults have consistently exhibited a higher incidence of stroke than their white counterparts 13 ; however, few studies have examined these racial disparities separately by sex or across stroke risk factors. 5, 6 Our findings suggest a moderately greater risk of total stroke among black women, albeit weaker than those previously reported. Several studies, including the NOMAS (Northern Manhattan Stroke Study) 5 and the ARIC study (Atherosclerosis Risk in Communities) have reported a nearly 3-fold greater risk of stroke among black compared with white women (NOMAS: relative risk=2.8, 95% CI, 2.0-3.8; ARIC: IR black=3.96, 95% CI, 3.10-5.06; and IR white=1.49, 95% CI, 1.16-1.92). 6 The older baseline age distribution (50-79 years) of the WHI compared with NOMAS and ARIC, may partially explain the attenuated racial disparities we observed and highlights the role of age in understanding racial disparities in stroke.
Our findings of significant variation of racial disparities in stroke by age were similar, albeit attenuated, to previous reports. In age-stratified analyses, the greatest racial disparities in total stroke were among younger women even after adjustment for socioeconomic and stroke risk factors, while minimal disparities were observed among women aged ≥70 years and were no longer significant in fully adjusted models. In analyses stratified by race and additionally adjusted for stroke risk factors, the age-related risk of total stroke was greater among white than among black women on the relative scale because of the higher baseline risk of stroke among younger black women. The lack of diminishing absolute rates by age was likely because of the sharp increase in the incidence of stroke among older compared with younger white women ( Figure 2B ). Similar to our findings, among participants of REGARDS in unadjusted analyses, blacks aged 45 to 54 years exhibited a significant 4-fold greater risk of total stroke (95% CI, 1.23-13.11) compared with whites, with no significant association observed for those aged ≥75 years. 4 Older black women may represent a survivor cohort or the role of race on health may be diminished by chronic disease in older age. Additionally, because of historical differences in the distribution of cardiovascular factors, older women in our cohort may have been exposed to cardiovascular risk factors at older ages, attenuating their influence on stroke risk. Moreover, racial variation in stroke risk by family history of stroke has not been previously reported. These findings suggest that genetic predisposition to stroke is unlikely to explain racial disparities, further supporting the role of social and environmental factors in shaping these disparities.
These findings have several key implications and highlight the importance of examining disparities across multiple Model 1: Adjusted for age and time-varying effects for enrollment in extended follow-up and stratified by treatment arm. Model 2: Model 1 and socioeconomic factors (marital/partnership status, highest level of attained education, household income, region of residence, last usual medical care provider visit within last year). Model 3: Model 2 and stroke risk factors (smoking status, systolic blood pressure, diastolic blood pressure, hypertension status, antihypertensive medication, hyperlipidemia medication, diabetes mellitus, atrial fibrillation, history of cancer, BMI, hormone therapy use, alcohol consumption, weekly minutes of physical activity, Healthy Eating Index-2005 score, and family history of stroke). BMI indicates body mass index; and HR, hazards ratio. *Unknown strokes: n=500 (black women n=439, white women n=61). †P<0.05.
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dimensions of the lived experience, for example, across race, sex, and age. Younger black women have been shown to carry a disproportionate burden of stroke risk factors beginning at earlier ages than their white counterparts. The attenuated magnitude of racial disparities among black women in our cohort compared with previous findings [4] [5] [6] 14 suggests a key role of socioeconomic factors underlying racial inequities in stroke. Overall, both black and white women in this WHI sample had somewhat better health status and higher educational status than women in REGARDS. They were less likely to be current smokers ( 15 and black women were more likely to have achieved college or postgraduate education in WHI (36%) than in REGARDS (22%). 16 These differences may also explain the lack of variation in racial disparities across other risk factors, in contrast to previous findings for SBP and diabetes mellitus. 8, 17 Although higher socioeconomic status may attenuate racial disparities in stroke, the elevated stroke incidence among younger black women and those without a family history of stroke, may reflect persistent racial differences in the distribution of deleterious exposures at the individual, neighborhood, and institutional levels across the life course. It is uncertain whether stroke risk factors may influence risk differently not just across various life stages but whether the layering of risk life across particular life stages may confer or alter stroke risk. Unequal access to material and social resources and psychological stress among black women may result in accelerated cardiovascular aging, because of a longer duration and heavier burden of stroke risk factors potentially beginning in childhood, inequities in stroke incidence and ultimately greater years of life and productivity lost than similarly aged white women. 18 Additionally, research is needed to understand the role of positive social constructs within US black communities that can support resiliency and mitigate such inequities in health attainment.
Important strengths and limitations of this study warrant consideration. The long follow-up and large sample size allowed for the accrual of ample events to conduct withinrace comparisons across stroke risk factors which provided improved interpretability by using relevant reference groups (ie, within-race comparisons). In contrast, comparisons across racial groups may suffer from residual confounding because of unmeasured confounders and inequities in the comparability of socioeconomic measures, quality or access to care, or compliance to medication. The minimal confounding by socioeconomic factors observed in our multivariable analyses may reflect limitations of education and income to capture nuances of access to social and material resources or childhood socioeconomic factors. Additionally, analyses exploring generational differences may elucidate potential cohort effects. Moreover, the higher prevalence of atrial fibrillation among black women and differences in anticoagulant use may also inform racial disparities in stroke. While generalizability may be limited, any potential bias would be expected to be towards the null. Moreover, potential misclassification because of self-report was minimized by standardized clinical measurements of BP and anthropometrics and medication inventories. Despite ample total stroke events, the power to examine stroke types was limited because of few hemorrhagic strokes among black women. Last, this study was not originally powered to examine interaction analyses; therefore, chance findings associated with evaluation of multiple subgroups may potentially explain the observed heterogeneity.
In conclusion, in this cohort of middle-to-older aged women, free of cardiovascular disease at baseline, we found a moderately greater risk of total stroke among black compared with white women. However, the association varied significantly by age and family history of stroke. These findings highlight the greater impact of stroke among young black women and suggest racial disparities in stroke risk may be reduced by environmental, clinical and behavioral interventions targeted at younger black women to address inequities in the burden of stroke risk factors. 
